Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fiedler

Showing results (81-90 of 195) with videos related to

Pageof 20
Sort By:
Cancers|June 10, 2022
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective TreatmentSusanne Ghandili, Philipp H von Kroge, Marcel Simon, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancerEckart Laack, Thorsten Dierlamm, Claudia Knuffmann, et al.
Immunology Letters|January 4, 2026
Enrichment of CD103⁺CD4⁺ T Cells in Bone Metastases Compared to Non-Malignant ControlsElias Brauneck, Julian Kylies, Anne Marie Assemissen, et al.
Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.
Haematologica|August 25, 2022
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemiaWalter Fiedler, Pau Montesinos, Christoph Schliemann, et al.
Cells|March 25, 2022
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian CancerPauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, et al.
British Journal of Haematology|November 22, 2020
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantronePanagiotis Karagiannis, Winfried Alsdorf, Ann-Christin Tallarek, et al.
Cellular Signalling|December 2, 2014
ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy conceptsMaxim Kebenko, Astrid Drenckhan, Stephanie J Gros, et al.
Leukemia Research|August 14, 2009
An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemiaWalter Fiedler, Rolf Mesters, Michael Heuser, et al.
Haematologica|June 30, 2022
Clinical features of hepatitis E infections in patients with hematologic disordersSusanne Ghandili, Cecilia Lindhauer, Sven Pischke, et al.
Pageof 20

Showing results (81-90 of 195) with videos related to

Sort By:
Pageof 20
Cancers|June 10, 2022
Diagnostic Utility of Bronchoalveolar Lavage in Patients with Acute Leukemia under Broad-Spectrum Anti-Infective TreatmentSusanne Ghandili, Philipp H von Kroge, Marcel Simon, et al.
Lung Cancer (Amsterdam, Netherlands)|May 16, 2002
Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancerEckart Laack, Thorsten Dierlamm, Claudia Knuffmann, et al.
Immunology Letters|January 4, 2026
Enrichment of CD103⁺CD4⁺ T Cells in Bone Metastases Compared to Non-Malignant ControlsElias Brauneck, Julian Kylies, Anne Marie Assemissen, et al.
Haematologica|March 13, 2025
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemiaFelix Klingler, Anika Forstreuter, Luisa Stegat, et al.
Haematologica|August 25, 2022
An open-label, phase I/II trial to determine the maximum tolerated dose and investigate safety, pharmacokinetics and efficacy of BI 836858, an unconjugated anti-CD33 monoclonal antibody, in combination with decitabine in patients with acute myeloid leukemiaWalter Fiedler, Pau Montesinos, Christoph Schliemann, et al.
Cells|March 25, 2022
Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian CancerPauline Weimer, Jasmin Wellbrock, Tabea Sturmheit, et al.
British Journal of Haematology|November 22, 2020
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantronePanagiotis Karagiannis, Winfried Alsdorf, Ann-Christin Tallarek, et al.
Cellular Signalling|December 2, 2014
ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: identification of novel targets for concerted therapy conceptsMaxim Kebenko, Astrid Drenckhan, Stephanie J Gros, et al.
Leukemia Research|August 14, 2009
An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemiaWalter Fiedler, Rolf Mesters, Michael Heuser, et al.
Haematologica|June 30, 2022
Clinical features of hepatitis E infections in patients with hematologic disordersSusanne Ghandili, Cecilia Lindhauer, Sven Pischke, et al.
Pageof 20